What is Pharmacovigilance?
The main goals of Pharmacovigilance are to improve patient health and safety with respect to the use of pharmaceutical products and to support public health programmes providing reliable and prompt information for the ongoing evaluation of drugs risk-benefit profile.
The European legislation on Pharmacovigilance imposes on all healthcare professionals and citizens to report any suspected adverse reaction.
It is an harmful and unintended response to:
In other European countries or Extra-EU countries:
In other European countries or Extra-EU countries, the adverse reaction reporting is subject to local national requirements.
Please contact the healthcare professional in your countries to properly report any adverse reaction to pharmaceutical products.